Skip to content
Governance Register

← US public companies

Sagent Pharmaceuticals, Inc.

SEC CIK 1369786 · [NONE] · last insider filing 2016-09-01

Directors (from insider filings)

NameCapacity as filedFilings
Flanagan Robert J Director filed 2011 - 2016
Behrens Mary Taylor Director filed 2011 - 2016
Krizman Anthony Director filed 2011 - 2016
Yanai Shlomo Director filed 2015 - 2016
Fekete Michael Director filed 2013 - 2016
Oberman Allan Director · Chief Executive Officer filed 2015 - 2016
Kung Frank Director filed 2011 - 2015
Yordon Jeffrey Director · Chief Executive Officer filed 2011 - 2015
Yu Chen-Ming Director · Interim COO filed 2011 - 2012
Sperans James Director filed 2011 - 2012

Officers (from insider filings)

NameTitle as filedFilings
Harmon J Frank EVP, Global Operations filed 2016 - 2016
Singer Jonathon M EVP and CFO filed 2011 - 2016
Greve Jeffrey W. Vice President, Controller filed 2012 - 2016
Ward Michael V. Chief Legal Off. and Secretary filed 2016 - 2016
Brynjelsen Sean EVP, Business Development filed 2016 - 2016
Bullock Donald R Executive V.P. Sales filed 2016 - 2016
Patterson Albert Senior VP, Operations filed 2011 - 2016
Logerfo Michael President, CLO and Secretary filed 2011 - 2016
Drake Lorin VP, Sales and Marketing filed 2011 - 2016
Shea Thomas Joseph VP, Global Alliance Management filed 2015 - 2016
Hussey James M President filed 2013 - 2015
Pauli Ronald Chief Financial Officer filed 2011 - 2012
Hebeda Dave Vice President, Finance filed 2011 - 2012

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.